Peer2Me: A Peer-Supported Program for AYA Cancer Patients
Study Protocol of a Randomised Trial Using a Comprehensive Cohort Design
Background: Young adult cancer patients often experience psychological distress and unmet support needs. The Peer2Me intervention aims to provide peer support to AYA cancer patients to enhance self-efficacy and coping with the disease.
Methods: The study will enroll 180 AYA patients in active cancer treatment, randomized to receive the Peer2Me intervention or a single AYA-specific consultation. Mentees and mentors are matched based on diagnosis, age, and gender. The primary outcome is self-efficacy, with secondary outcomes including anxiety, depression, health literacy, life satisfaction, and social support. Measurements will be taken at baseline, immediately after the intervention, and three months post-intervention.
Discussion: Peer2Me could be a valuable addition to professional support services for young cancer patients. The study aims to make a psycho-oncological intervention available for both mentors and mentees, with plans for long-term continuity.
Trial Registration: The study was retrospectively registered on clinicaltrials.gov (NCT05336318).
Clinical Trials and AI-Driven Solutions
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates clinical protocols and research into an easily accessible knowledge base for clinicians. Additionally, our mobile apps support scheduling, treatment monitoring, and telemedicine, streamlining operations and improving patient care.
AI-driven solutions can enhance clinic workflows and improve patient outcomes, reducing paper routines. Learn more at aidevmd.com.
